CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

Plastic surgery, weight reduction, and her complex connection with food are just a few of the personal issues that Sharon ...

President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...

Trump’s administration has taken a significant step by pulling back on a controversial Biden-era plan to expand Medicare and Medicaid coverage for anti-obesity medications, a move that reflects fiscal ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The decision will not impact Medicare's existing coverage for drugs like Ozempic and Mounjaro, which can be used for weight ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...